| Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project ENCODE Project Consortium Nature 447 (7146), 799, 2007 | 4920 | 2007 |
| The landscape of histone modifications across 1% of the human genome in five human cell lines CM Koch, RM Andrews, P Flicek, SC Dillon, U Karaöz, GK Clelland, ... Genome research 17 (6), 691-707, 2007 | 427 | 2007 |
| Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation OM Dovey, CT Foster, SM Cowley Proceedings of the National Academy of Sciences 107 (18), 8242-8247, 2010 | 237 | 2010 |
| A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia K Tzelepis, H Koike-Yusa, E De Braekeleer, Y Li, E Metzakopian, ... Cell reports 17 (4), 1193-1205, 2016 | 185 | 2016 |
| Accurate and reliable high-throughput detection of copy number variation in the human genome H Fiegler, R Redon, D Andrews, C Scott, R Andrews, C Carder, R Clark, ... Genome research 16 (12), 1566-1574, 2006 | 167 | 2006 |
| Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability CT Foster, OM Dovey, L Lezina, JL Luo, TW Gant, N Barlev, A Bradley, ... Molecular and cellular biology 30 (20), 4851-4863, 2010 | 150 | 2010 |
| Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes A Rada-Iglesias, S Enroth, A Ameur, CM Koch, GK Clelland, ... Genome research 17 (6), 708-719, 2007 | 126 | 2007 |
| Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse R Natrajan, RD Williams, SN Hing, A Mackay, JS Reis‐Filho, K Fenwick, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 125 | 2006 |
| Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice OM Dovey, CT Foster, N Conte, SA Edwards, JM Edwards, R Singh, ... Blood 121 (8), 1335-1344, 2013 | 95 | 2013 |
| Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays A Rada-Iglesias, O Wallerman, C Koch, A Ameur, S Enroth, G Clelland, ... Human molecular genetics 14 (22), 3435-3447, 2005 | 93 | 2005 |
| Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells S Jamaladdin, RDW Kelly, L O’Regan, OM Dovey, GE Hodson, CJ Millard, ... Proceedings of the National Academy of Sciences 111 (27), 9840-9845, 2014 | 74 | 2014 |
| Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ... Nature 554 (7690), 62, 2018 | 60 | 2018 |
| A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice A Mupo, L Celani, O Dovey, JL Cooper, C Grove, R Rad, P Sportoletti, ... Leukemia 27 (9), 1917, 2013 | 54 | 2013 |
| Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia S Picaud, K Leonards, JP Lambert, O Dovey, C Wells, O Fedorov, ... Science advances 2 (10), e1600760, 2016 | 39 | 2016 |
| Loss of Rassf1a cooperates with ApcMin to accelerate intestinal tumourigenesis L Van der Weyden, MJ Arends, OM Dovey, HL Harrison, G Lefebvre, ... Oncogene 27 (32), 4503, 2008 | 37 | 2008 |
| Loss of Rassf1a cooperates with ApcMin to accelerate intestinal tumourigenesis L Van der Weyden, MJ Arends, OM Dovey, HL Harrison, G Lefebvre, ... Oncogene 27 (32), 4503, 2008 | 37 | 2008 |
| Emphasizing the positive: A role for histone deacetylases in transcriptional activation OM Dovey, CT Foster, SM Cowley Cell cycle 9 (14), 2700-2701, 2010 | 26 | 2010 |
| UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs M Gozdecka, E Meduri, M Mazan, K Tzelepis, M Dudek, AJ Knights, ... Nature genetics 50 (6), 883, 2018 | 23 | 2018 |
| Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia OM Dovey, JL Cooper, A Mupo, CS Grove, C Lynn, N Conte, RM Andrews, ... Blood 130 (17), 1911-1922, 2017 | 18 | 2017 |
| Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage J Li, D Prins, HJ Park, J Grinfeld, C Gonzalez-Arias, S Loughran, ... Blood 131 (6), 649-661, 2018 | 16 | 2018 |
